[ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ]
Fırat Tıp Dergisi
[ Turkish ] [ PDF ]
Evaluation of Axillary Sentinel Lymph Node Biopsy By Combined Blue Dye and Lymphoscintigraphy Method
İbrahim ATAK1, Candan COŞKUN2, Tuba ATAK3, Lütfi POLAT1, Murat ÇALIKAPAN1, Serkan Fatih YEĞEN1, Erol BAĞCIVAN1
1Ali Osman Sönmez Onkoloji Hastanesi, Genel Cerrahi Kliniği, Bursa, Türkiye
2Ali Osman Sönmez Onkoloji Hastanesi, Nükleer Tıp Kliniği, Bursa, Türkiye
3Çekirge Devlet Hastanesi, Genel Cerrahi Kliniği, Bursa, Türkiye

Objective: The most important prognostic factor of breast cancer is the status of the axillary lymph nodes regarding tumor metastasis. Recently, sentinel lymph node biopsy (SLNB) has replaced axillary lymph node dissection in early-stage breast cancer. In this study, it was aimed to assess the results of axillary sentinel lymph node biopsy by combined method.

Material and Method: The data of 52 patients with early-stage (T1-T2, N0) breast cancer undergoing surgery between July 2015 and April 2017 were reviewed retrospectively. All of the surgical operations were performed by the same surgeon. Breast-conserving surgery and sentinel lymph node biopsy with the combined technique was performed in all patients. Demographic data, preoperative stages, number of sentinel lymph nodes, postoperative complications were recorded. Sentinel lymph node detection rates of procedures were calculated individually.

Results: All of the patients were females and the mean age was 48.2 (33-78) years. Average number of sentinel lymph nodes removed by blue dye was 1.5 (1-4). One sentinel lymph node was detected in 21 patients, 2 in 22 patients, 3 in 4 patients and 4 in 1 patient. Average number of sentinel lymph nodes detected with lymphoscintigraphy was 2.1 (1-5). One sentinel lymph node was detected in 5 patients, 2 in 32 patients, 3 in 10 patients, 4 in 2 patients and, 5 in 1 patient. While sentinel lymph node was detected with lym-phoscintigraphy in 3 patients despite no staining occurred with methylene blue, sentinel lymph node which could not be detected with lymphoscintig-raphy was detected with blue dye in one patient. Sentinel lymph node detection rates of methylene blue, lymphoscintigraphy and combined technique were determined to be 92.3%, 96.1% and 98%; respectively.

Conclusion: Combined method is a safe and applicable method with high accuracy rate in sentinel lymph node detection for the management of patients with early-stage breast cancer.


[ Turkish ] [ PDF ]
[ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ]